Michael Thurn
Director/Board Member at Marp Therapeutics Pty Ltd.
Michael Thurn active positions
Companies | Position | Start | End |
---|---|---|---|
Marp Therapeutics Pty Ltd.
Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Marp Therapeutics Pty Ltd. provides therapy services. The company is based in Melbourne, Australia. | Director/Board Member | - | - |
Career history of Michael Thurn
Former positions of Michael Thurn
Companies | Position | Start | End |
---|---|---|---|
PHARMAUST LIMITED | Chief Executive Officer | 2023-08-31 | 2024-04-22 |
BOTANIX PHARMACEUTICALS LIMITED | Director/Board Member | 2019-02-11 | 2020-02-25 |
Chief Operating Officer | 2017-02-13 | 2020-02-25 | |
ERASCA, INC. | Director/Board Member | - | - |
Therapeutic Goods Administration | Corporate Officer/Principal | 2011-06-14 | - |
KAZIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - | - |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Corporate Officer/Principal | - | - |
YM BioSciences Australia Pty Ltd.
YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Chief Operating Officer | - | - |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Michael Thurn
University of Technology Sydney | Doctorate Degree |
Statistics
International
Australia | 11 |
United States | 2 |
Operational
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
KAZIA THERAPEUTICS LIMITED | Health Technology |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
PHARMAUST LIMITED | Health Technology |
ERASCA, INC. | Health Technology |
Private companies | 6 |
---|---|
YM BioSciences Australia Pty Ltd.
YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Health Technology |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
Mimetica Pty Ltd.
Mimetica Pty Ltd. Pharmaceuticals: MajorHealth Technology Mimetica Pty Ltd. is a holding company, which engages in the development of products for the treatment of acne. It has a drug discovery platform technology based on the rational design of small molecules that mimic natural peptide hormones. The company was founded in 2001 and is headquartered in Southbank, Australia. | Health Technology |
Spinifex Pharmaceuticals Pty Ltd.
Spinifex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Spinifex Pharmaceuticals Pty Ltd. discovers and develops new drugs for the treatment and management of pain. The firm conducts medicinal chemistry and drug discovery activities, preclinical and early-phase clinical studies before seeking a partnership with pharmaceutical company to complete clinical development, file for regulatory approval, and carry out marketing activities. The company was founded in June 2005 and is headquartered in Preston, Australia. | Health Technology |
Therapeutic Goods Administration | |
Marp Therapeutics Pty Ltd.
Marp Therapeutics Pty Ltd. Medical/Nursing ServicesHealth Services Marp Therapeutics Pty Ltd. provides therapy services. The company is based in Melbourne, Australia. | Health Services |
- Stock Market
- Insiders
- Michael Thurn
- Experience